Company: NCEL
Filing Date: 2025-03-31
Form Type: 425
Source: 0001213900-25-025889
Chunk: 24

Company: NewcelX Ltd.
Filing Date: 2025-03-31
Form: 425
Chunk 24
---
 any property or asset of the Company or any Subsidiary
is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court, governmental authority or Trading Market to which the Company or
a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company
or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected
to result in a Material Adverse Effect. Except as set forth in the SEC Reports, no shareholder of the Company has any subscription rights
or rights of participation in the transactions contemplated by this Agreement.

<div align='center'>13</div>

(e) . The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing
or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the
execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant to this
Agreement, (ii) the filing with the Commission of the Registration Statement, (iii) implementation of the Capital Increase and filing
of the Application with the commercial register of the canton of Zurich, and (iv) the filing of a Form D with the Commission and such
filings as are required to be made under applicable state securities laws (collectively, the “”).
Specifically, the Company has obtained all necessary approval from, its Board of Directors, its shareholders, and the Nasdaq Capital Market,
and all holders of any securities of the Company, as necessary to fulfill its obligations hereunder.

(f) .
The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction Documents, will be duly
and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer
provided for in the Transaction Documents. The Securities, when issued in accordance with the terms of the Transaction Documents, will
be validly issued, fully paid and nonassessable, free and clear of all Liens other than restrictions on transfer provided for in the Transaction
Documents. The Company has, subject to shareholder approval, reserved